Core B: Developmental Core Staff of the core will include Core Director John M. Coffin, Ph.D. He is Professor of Molecular Biology and Microbiology, Tufts University School of Medicine. Dr. Coffin is a leading figure in research on the biology of retroviruses. Dr. Coffin's responsibilities will be to oversee the process of soliciting, reviewing and awarding developmental funding, and to initiate a program to encourage the recruitment and development of minority scientists. Basic purposes of the core will be 1) to provide developmental awards through a peer-reviewed process in order to encourage new research and to attract new investigators to the HIV/AIDS research field; 3) to expand the number of investigators from under-represented minority groups who are active in the field of AIDS research. Developmental Funds will be earmarked to three types of projects: pilot projects involving established AIDS investigators who desire to develop data regarding a hypothesis that may result in a full RO1 submission; Initial AIDS research projects that involve investigators new the AIDS research fielding initiating an HIV/AIDS research; and collaborative projects that allow two or more established investigators to form a creative collaboration that will produce synergy between the research being performed in different disciplines.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Miriam Hospital
United States
Zip Code
Gnatienko, Natalia; Freiberg, Matthew S; Blokhina, Elena et al. (2018) Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia. HIV Clin Trials 19:101-111
Olney, Jack J; Eaton, Jeffrey W; Braitstein, Paula et al. (2018) Optimal timing of HIV home-based counselling and testing rounds in Western Kenya. J Int AIDS Soc 21:e25142
Brinkley-Rubinstein, Lauren; McKenzie, Michelle; Macmadu, Alexandria et al. (2018) A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend 184:57-63
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens. J Clin Virol 99-100:1-4
Lally, Michelle A; van den Berg, Jacob J; Westfall, Andrew O et al. (2018) HIV Continuum of Care for Youth in the United States. J Acquir Immune Defic Syndr 77:110-117
Schechter-Perkins, Elissa M; Miller, Nancy S; Hall, Jon et al. (2018) Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program. Acad Emerg Med :
Reece, Rebecca; Delong, Allison; Matthew, D'Antuono et al. (2018) Accumulated pre-switch resistance to more recently introduced one-pill-once-a-day antiretroviral regimens impacts HIV-1 virologic outcome. J Clin Virol 105:11-17
Wachira, Juddy; Genberg, Becky; Kafu, Catherine et al. (2018) Experiences and expectations of patients living with HIV on their engagement with care in Western Kenya. Patient Prefer Adherence 12:1393-1400
Stone, Andrew C; Carroll, Jennifer J; Rich, Josiah D et al. (2018) Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months. Drug Alcohol Depend 192:94-97
Chan, Philip A; Montgomery, Madeline C; Rose, Jennifer et al. (2018) Statewide Evaluation of New HIV Diagnoses in Rhode Island: Implications for Prevention. Public Health Rep 133:489-496

Showing the most recent 10 out of 806 publications